Spitalul Clinic De Boli Infectioase Si Tropicale Dr. Victor Babes — Clinical Trial Site

14 Registered trials

6 Currently recruiting

Organisation

Spitalul Clinic De Boli Infectioase Si Tropicale Dr. Victor Babes

Location

Bucharest, Romania

Identifier

ORG-100032530

Address

Soseaua Mihai Bravu Nr 281 Sector 3, 030303, Romania

Departments

2902; Infectious diseases
Boli Infectioase Sectia IV, Sector3
Boli Infecțioase si tropicale
Infectious and Tropical Diseases
Infectious and Tropical Diseases Adults V Department
Infectious Diseases
NA
Sectia Clinica VI Adulti
Sectia Clinica VI-Adulti
Sectia Dispensarizare hepatite

Clinical trials at this site (14)

Search interface

Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide Recruiting

2025-522015-42-00 Chronic Hepatitis D Infection 10 2026-02-26
Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and H… Recruiting

2025-521178-33-00 Chronic Hepatitis B Virus Infection 4 2025-12-03
A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta I… Recruiting

2024-517167-23-00 Chronic Hepatitis D Infection 5 2025-08-28
A Study to Evaluate Tobevibart+Elebsiran in Participants with Chronic HDV Infection Not Virologically Suppressed with Bulevirtide Recruiting

2024-519282-22-00 Chronic Hepatitis D Virus (HDV) Infection 5 2025-07-09
Clinical trial of molnupiravir (MK-4482) in adults who have COVID-19 and are not hospitalized, who are at high risk for serious illness from… Recruiting

2023-507227-36-00 SARS-CoV-2 (COVID-19) infection 5 2025-02-21
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides difficile Infection: The Re… Recruiting

2022-502972-22-00 Clostridioides difficile infection. 5 2024-10-31
A Phase 3 Trial Comparing Whether BEM/RZR is Similar to SOF/VEL in Patients with Hepatitis C Virus Infection Ended

2025-521096-31-00 Chronic Hepatitis C Virus (HCV) Infection 5 2025-10-02
A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV Infection Ended

2024-520062-54-00 Chronic Hepatitis D Virus (HDV) Infection 4 2025-07-23
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection Ended

2024-515919-22-00 Chronic Hepatitis D Virus (HDV) Infection 5 2025-06-02
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection Ended

2022-501901-10-00 Chronic Hepatitis D Infection 6 2023-02-06
Long-term follow-up study to evaluate durability of treatment response in previous bepirovirsen study participants (B-Sure). Ended

2023-506867-33-01 Chronic Hepatitis B 4 2022-01-25
STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BEMNIFOSBUVIR AND RUZASVIR IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION Ended

2023-504566-28-00 Chronic Hepatitis C Virus (HCV) Infection 4 2023-05-19
A study to evaluate the efficacy and safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19 Ended

2023-504540-33-00 COVID-19 5 2023-03-06
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17